Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoichi Ohtake

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Oncologist|November 25, 2022
Morphine Versus Oxycodone for Cancer Pain Using a Catechol-O-methyltransferase Genotype Biomarker: A Multicenter, Randomized, Open-Label, Phase III Clinical Trial (RELIEF Study)Hiromichi Matsuoka, Junji Tsurutani, Yasutaka Chiba, et al.
BMC Medical Education|February 11, 2021
A model six-month workshop for developing systematic review protocols at teaching hospitals: action research and scholarly productivityHiraku Tsujimoto, Yuki Kataoka, Yukihito Sato, et al.
Oncology Letters|August 7, 2023
Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer painYoshihiko Fujita, Hiromichi Matsuoka, Yasutaka Chiba, et al.
Journal of Pain and Symptom Management|June 30, 2019
Additive Duloxetine for Cancer-Related Neuropathic Pain Nonresponsive or Intolerant to Opioid-Pregabalin Therapy: A Randomized Controlled Trial (JORTC-PAL08)Hiromichi Matsuoka, Satoru Iwase, Tempei Miyaji, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 26, 2019
Predictors of duloxetine response in patients with neuropathic cancer pain: a secondary analysis of a randomized controlled trial-JORTC-PAL08 (DIRECT) studyHiromichi Matsuoka, Satoru Iwase, Tempei Miyaji, et al.
Kidney International|January 5, 2024
Conservative kidney management and kidney supportive care: core components of integrated care for people with kidney failureSara N Davison, Wolfgang Pommer, Mark A Brown, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Oncologist|November 25, 2022
Morphine Versus Oxycodone for Cancer Pain Using a Catechol-O-methyltransferase Genotype Biomarker: A Multicenter, Randomized, Open-Label, Phase III Clinical Trial (RELIEF Study)Hiromichi Matsuoka, Junji Tsurutani, Yasutaka Chiba, et al.
BMC Medical Education|February 11, 2021
A model six-month workshop for developing systematic review protocols at teaching hospitals: action research and scholarly productivityHiraku Tsujimoto, Yuki Kataoka, Yukihito Sato, et al.
Oncology Letters|August 7, 2023
Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer painYoshihiko Fujita, Hiromichi Matsuoka, Yasutaka Chiba, et al.
Journal of Pain and Symptom Management|June 30, 2019
Additive Duloxetine for Cancer-Related Neuropathic Pain Nonresponsive or Intolerant to Opioid-Pregabalin Therapy: A Randomized Controlled Trial (JORTC-PAL08)Hiromichi Matsuoka, Satoru Iwase, Tempei Miyaji, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 26, 2019
Predictors of duloxetine response in patients with neuropathic cancer pain: a secondary analysis of a randomized controlled trial-JORTC-PAL08 (DIRECT) studyHiromichi Matsuoka, Satoru Iwase, Tempei Miyaji, et al.
Kidney International|January 5, 2024
Conservative kidney management and kidney supportive care: core components of integrated care for people with kidney failureSara N Davison, Wolfgang Pommer, Mark A Brown, et al.
Pageof 2